Document is current

Article History

Received: 2 April 2024

Accepted: 21 August 2024

First Online: 26 October 2024

Acknowledgements

: Editorial assistance in the preparation of this article was provided by R. Brines of Bite Medical Consulting, who collated author drafts and changes, and proofread successive drafts of the manuscript prior to submission. Financial support for this assistance was provided by Abbott Diabetes Care. Parts of this study were presented at the 59th Annual Meeting of the EASD, Hamburg, Germany, 2–6 October 2023.

: Data not presented in the analysis are available on request from the authors.

: Open access funding provided by Karolinska Institute. Financial support for this study was provided by Abbott Diabetes Care.

: DN received honoraria from Abbott for the work within this study. KE-O has received fees for lecturing and/or honoraria for consulting from Sanofi, Novo Nordisk, Eli Lilly and Abbot Diabetes Care. TS has received compensation for serving on scientific advisory boards and honoraria for consultancy from Biogen, as well as speaker honoraria from Novartis. MK is employed by Synergus RWE, which received reimbursement from Abbott to perform the analysis. FL-G is an employee of Abbott Diabetes Care. JB has received honoraria for consulting and/or lecture fees from Abbott Diabetes Care, MannKind Corporation, Nanexa, Nordic InfuCare, Novo Nordisk and Sanofi.

: DN, KE-O and JB are the guarantors of this work, and, as such, had full access to all the data in the study, and take responsibility for the integrity of the data and the accuracy of the data analysis. All authors contributed to the methodology, analyses and manuscript writing. All authors gave their approval for this version to be published.